Article info

Download PDFPDF

Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

Authors

  1. Correspondence to Dr Baruch D Kuppermann, Department of Ophthalmology, Gavin Herbert Eye Institute, UC, Irvine, 850 Health Sciences Road, Irvine, CA 92697, USA; bdkupper{at}uci.edu
View Full Text

Citation

Malik D, Tarek M, Caceres del Carpio J, et al
Safety profiles of anti-VEGF drugs: bevacizumab, ranibizumab, aflibercept and ziv-aflibercept on human retinal pigment epithelium cells in culture

Publication history

  • Received March 25, 2014
  • Accepted March 30, 2014
  • First published May 17, 2014.
Online issue publication 
May 17, 2014

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.